| Category | Min Lots | Shares | Amount |
|---|---|---|---|
| Retail (sNII) | 2 | 2,400 | ₹2,73,600 |
| HNI / NII | 3 | 3,600 | ₹4,10,400 |
| Category | Sub (×) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 29,28,000 (47.39%) | — | ₹3,337.92 Cr |
| NII / HNI (Total) | — | 8,82,000 (14.27%) | — | ₹1,005.48 Cr |
| Retail Investors | — | 20,59,200 (33.33%) | — | ₹2,347.49 Cr |
| Total ** | — | 61,78,800 (100.00%) | — | ₹70,438.32 Cr |
| Market Maker * | — | 3,09,600 (5.01%) | — | ₹35.29 Cr |
| Metric | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue | 84.04 | 267.17 | 162.83 |
| PAT | 4.10 | 12.94 | 5.22 |
| EBITDA | 8.04 | 24.64 | 13.36 |
| Net Worth | 53.50 | 49.42 | 24.66 |
| Total Assets | 218.87 | 188.35 | 112.07 |
| Reserves | 35.73 | 31.66 | 23.41 |
| Borrowings | 57.72 | 58.11 | 54.63 |
Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration and export of finest crop protection products and bioproducts for crop & soil health management and to help the farming community for more productivity.
The company specializes in manufacturing pesticide formulations and supplying bulk products to Indian agrochemical companies and multinational corporations (MNCs).
The company imports carefully researched molecules, registers them with the Central Insecticides Board, and markets them as technical and value-added formulations for domestic manufacturers and multinational corporations (MNCs).
The company has invested in global product registrations, with active markets in countries like the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey, offering high-quality products and data support for registrations.
Product Portfolio:
Competitive Strengths: